Publication barcelona eaap 2009

Preview:

Citation preview

A new freezing extender for stallion semen

to get high fertility rates INRA-Freeze®

Elodie Pillet, G. Duchamp, F. Batellier, J.M. Yvon, G. Delhomme, S. Desherces, E. Schmitt, M. Magistrini.

BUT

Artificial insemination with frozen semen

A lot of advantages

A few limits

Transport of semen is easier

Storage can be unlimited

Choice of stallion is wider

Results are lower or more fluctuating

Freezing extenders are not optimal, and not practical

Have to be prepared in the lab

Contain milk and/or egg yolk

than with fresh or chilled semenIn France, in the National Studs: 2007: Fertility/cycle = 44%44% (2557 cycles) 2008: Fertility/cycle = 47%47% (2270 cycles)(55% with fresh semen in the National Studs)

For the success of artificial insemination

Freezing extender = a key factor

Objective :

To develop a freezing extender

able to improve fertility results

easy to use

able to avoid sanitary risks

in vitro analyses + in vivo trials 2 steps : ► 1) To remove milk

► 2) To remove egg yolk (EY)

2 in vivo trials

INRA - Nouzilly

Experimental herd : 120 mares

► 1) To remove milkFertility Trial 1

1st dilution

2nd dilution and freezing

INRA82+ 2% EY

+ 2,5% glycerol

INRA82

INRA96®

(only caseins of milk)

+ EY + glycerol

INRA96®

+ 2% EY+ 2,5% glycerol

INRA96®(Palmer, 1984) (Batellier et al., 1997)

Insemination Protocol :

induction of ovulation (CEG)

1 dose of insemination

400 x 106 sperm cells

6 hours before expected ovulation

insemination in the uterine body

0

20

40

60

80

100

Stallion 1 Stallion 2 Stallion 3

3 stallions, 7 ejaculates/stallion

84 mares’ cycles inseminated (72 mares)

INRA82 + EY + glycerol << INRA96® + EY + glycerol

0

20

40

60

80

100

Per-cycleFertility

(%)

p<0.01

71%30/42

INRA82+egg yolk+glycerol

INRA96®

+egg yolk+glycerol

40%17/42

(Pillet et al., 2008)

(milk based) (only caseins)

► 2) To remove egg yolkFertility Trial 2

plasma

granules

1) Contains Low DensityLipoproteins LDL

2) Can be sterilized

Sterilized Egg yolk plasma

Fractions of egg yolk

1st dilution

2nd dilution and freezing

INRA96®

+ 2% EY+ 2,5% glycerol

INRA96®

INRA96®

+ Sterilized EY plasma+ glycerol

INRA96®

+ 4% ster. EY plasma+ 2,5% glycerol

INRA96®

Insemination

70 mares’ cycles inseminated (68 mares)

0

20

40

60

80

100

p>0.05

Per-cycleFertility

(%)60%21/35

69%24/35

INRA96®

+EY+glycerol

INRA96®

+sterile EY plasma+glycerol

2 stallions, 8 ejaculates/stallion

0

20

40

60

80

100

Stallion 1 Stallion 2

INRA96® + EY + glycerol = INRA96® + + glycerolSterilizedEY plasma

Conclusion :

Fertility was greatly improved using INRA96® + egg yolk + glycerol OR

INRA96® + sterilized egg yolk plasma + glycerol

Can be incorporated into a ready to use extender

2 steps to develop a new freezing extender

INRA-Freeze®

2

1

2

INRA-Freeze®

Increases fertility results Is ready to use Avoids sanitary risks

69%69%(65% with fresh semen with

the same experimental herd at INRA)

Perspectives

CH3

lCH

3 – N + - l

CH3

C

H 3

l

CH 3 – N

+ - C 2 H 4 – OH

l

C

H 3

CH3

l

CH3 – N

+ - C2

l

CH3

Which molecule(s) ?

apoproteins

phospholipids

Which phospholipid ?

Which mechanism ?

INRA82 > INRA96 ®

INRA82+EY+GINRA96®+EY+G

Valeurs moyennes

0

20

40

60

80

100

VAP(µm.s-1) % PROG % RAP Paramètres de mobilité

****

******

INRA96 ® > INRA82

12 / 35 / 63 / 103 / 154 / 205 / 303 mOsm30

40

50

60

70

80

90

100% SPZ aux membranes

endommagées (marquage IP+)

INRA82+JO+GINRA96®+JO+G*% rapides : 61% > 58% (p<0,01)

Motility Membrane integrity

0

20

40

60

80

100

INRA82

spz à acrosomes intacts(%)

a

****

b

INRA96®

Resistance to oxidative stress

INRA82 > INRA96 ®INRA96 ® > INRA82 INRA82 = INRA96 ®

PSA-FITC

69% > 51% (p<0,0001)0,59 > 0,52 (p<0,0001)

Calcul du ratio :

fluo verte

(fluo rouge + verte)

020406080

100120140160180200

intensité de fluorescence FilipinIII

INRA82 INRA96®

aa

Non significatif

C11-Bodipy

Filipin III

Acrosome integrity

Cholesterol content

Motility results:Motility results:IVOS

0

10

20

30

40

50

60

70

80Valeursmoyennes

VAP (µm/s) % PROG % RAP30 % RAP40

a b

a a

a a a a

a,b : p < 0.001

Egg yolk

Plasma

Recommended